首页> Diabetes, obesity & metabolism> Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX).

Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX).

导出 LinkOut

翻译打印收藏纠错

第一作者： Dan J,Siskind

第一单位： Metro South Addiction and Mental Health Service, Brisbane, Australia.;School of Medicine, University of Queensland, Brisbane, Australia.;Queensland Centre for Mental Health Research, Brisbane, Australia.

作者： Dan J,Siskind ^[1] ; Anthony W,Russell ^[2] ; Clare,Gamble ^[3] ; Karl,Winckel ^[4] ; Karla,Mayfield ^[5] ; Sam,Hollingworth ^[6] ; Ingrid,Hickman ^[7] ; Victor,Siskind ^[8] ; Steve,Kisely ^[9]

作者单位： Metro South Addiction and Mental Health Service, Brisbane, Australia.;School of Medicine, University of Queensland, Brisbane, Australia.;Queensland Centre for Mental Health Research, Brisbane, Australia. ^[1] School of Medicine, University of Queensland, Brisbane, Australia.;Department of Endocrinology, Princess Alexandra Hospital, Brisbane, Australia. ^[2] Queensland Centre for Mental Health Research, Brisbane, Australia. ^[3] Department of Endocrinology, Princess Alexandra Hospital, Brisbane, Australia.;School of Pharmacy, University of Queensland, Brisbane, Australia. ^[4] Department of Pharmacy, Logan Hospital, Brisbane, Australia. ^[5] School of Pharmacy, University of Queensland, Brisbane, Australia. ^[6] Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, Australia.;Mater Research Institute, Brisbane, Australia. ^[7] Centre for Accident Research and Road Safety - Queensland, Queensland University of Technology, Brisbane, Australia. ^[8] Metro South Addiction and Mental Health Service, Brisbane, Australia.;School of Medicine, University of Queensland, Brisbane, Australia. ^[9]

关键词 GLP-1 agonists clozapine diabetes exenatide obesity